A Network for Connection, Healing, and Ongoing Resources
- Response deadline
- Aug 6, 2026 Closed
- Date posted
- Jul 7, 2026
- Source
- Open notice
Description
The Administration for Children and Families (ACF), through the Children's Bureau, will fund a cooperative agreement to develop, implement, and evaluate a demonstration program of post-adoption support services for birth parents who have voluntarily placed their children for private domestic adoption. This initiative is founded on the recognition that the well-being of all parties in an adoption is essential. Birth parents often benefit from access to support and resources following their placement for adoption.This demonstration program will provide services including, but not limited to, support groups and supportive services and resources. The goal is to identify and promote effective models of support that contribute to the positive adjustment and well-being of birth parents. A central component of this project is a rigorous evaluation to measure the effectiveness of the services provided and to develop a model that can be replicated by other organizations nationally. This work directly supports ACF's mission to promote the social well-being of families and individuals.
Classifications
- NAICS93.652
Documents (1)
- hhs-2026-acf-acyf-co-0041_v3.pdfapplication/pdf282 KBNot yet available
Contacts
Similar contracts
- Collaborative Approaches to Adoption for Children with Complex NeedsDue Aug 26, 2026
- Technology Enhanced Adoptive Family Recruiting and MatchingDue Aug 21, 2026
- Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)Due Mar 5, 2029
- NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 Independent Clinical Trial Not Allowed)Due May 26, 2027
- Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)Due Jan 10, 2028
- Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)Due Feb 8, 2028